Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Vaccine a plus-$value for Big Pharma...

<< Previous

Bullboard Posts

Next >>

Comment by Alamir1111on Apr 19, 2024 12:09pm

290 Views

Post# 35998195

RE:Vaccine a plus-$value for Big Pharma...

I'm pretty sure 5 year survival rate is considered free of disease.So a vaccine would mean that all those high tech laser equipment end up useless recyclables? ?Man that is another pp to be raised

For stage I NHL, the is more than 86%. For stage II the 5-year relative survival rate is 78%, and for stage III it is more than 72%. For stage IV NHL, the 5-year relative survival rate is almost 64%.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”